Health Care & Life Sciences » Biotechnology | GlycoMimetics Inc.

GlycoMimetics Inc.

GlycoMimetics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.18
Market Cap
$516.88 M
Shares Outstanding
43.18 M
Public Float
33.48 M

Profile

Address
9708 Medical Center Drive
Rockville Maryland 20850
United States
Employees -
Website http://www.glycomimetics.com
Updated 07/08/2019
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K.

Financials

View All

Rachel K. King
President, Chief Executive Officer & Director
John L. Magnani
Director, Chief Scientific Officer & SVP-Research